- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01420484
CNAP in Heart Surgery
Noninvasive Blood Pressure Measuring
The role of continuous non-invasive arterial pressure (CNAP) in high risk patients with pronounced variation of arterial pressure will be assessed under analgosedation.
Therefore, patients will be analyzed during normo-, hypo- and hypertension with standard IAP undergoing elective transfemoral aortic valve implantation procedures. Systolic, diastolic, and mean invasive arterial pressures (IAP) will be compared to those obtained by CNAP. Data will be analysed in different periods of arterial pressure for agreement of the two methods and for determination of precision (i.e. measurement error) and accuracy (i.e. systematic error). Additionally, we will compare both methods regarding the amplitude and time of very fast changes in arterial pressure during intervals of functional cardiac arrests (rapid pacing).
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Heidelberg, Germany, D-69120
- Medical Clinic, University of heidelberg
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Patients admitted for elective transfemoral implantation of the aortic valve in analgosedation will be included. The patients' primary diagnosis was severe aortic stenosis, that was defined as a valve area of <1cm² or a mean pressure gradient >50mmHg.
Exclusion criteria for the study will be an advanced dysfunction of peripheral perfusion (i.e. pronounced arterial peripheral artery occlusive disease or Raynaud's syndrome), arterio-venous shunts for haemodialysis, and vascular surgery of the upper extremities.
Before including patients in the present study, blood pressure will be measured on both arms noninvasively by oscillometry to exclude any significant arterial stenosis between the upper extremities. Differences of less than 10 mmHg will be accepted.
All patients won't receive any sedative drugs preoperatively and were allowed to drink fluids up to 2 hours before surgery.
Description
Inclusion Criteria:
- Patients admitted for elective transfemoral implantation of the aortic valve in analgosedation will be included.
- The patients' primary diagnosis was severe aortic stenosis, that was defined as a valve area of <1cm² or a mean pressure gradient >50mmHg.
Exclusion Criteria:
- an advanced dysfunction of peripheral perfusion (i.e. pronounced arterial peripheral artery occlusive disease or Raynaud's syndrome)
- arterio-venous shunts for haemodialysis, and vascular surgery of the upper extremities
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
different blood pressure intervals
|
In differnent blood presure intervals the IAP and CNAP measurement differences will be observed.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
blood pressure
Time Frame: blood pressure
|
blood pressure
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
age
Time Frame: age
|
descriptive data
|
age
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Christoph Schramm, MD, Department of Anesthesiology
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- S234/2009
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Transfemoral Implantation of Aortic Valves
-
Dr. Giuseppe MusumeciNot yet recruitingTransfemoral tranScatheter Aortic valvE ImplantationItaly
-
Shanghai Cingularbio Co. LtdCompleted
-
Closed Joint-Stock Company NeoCorResearch Institute for Complex Problems of Cardiovascular Diseases, Russia; CT Medical Limited Liability CompanyRecruitingDiseases of Mitral and Aortic Valves | Valvular Heart Disease (Aortic and Mitral Valves) | Rheumatic Disorders of Mitral and Aortic Valves | Other Congenital Malformations of Aortic and Mitral Valves | Mitral Valve Insufficiency and Aortic Valve InsufficiencyRussian Federation
-
Aarhus University Hospital SkejbyOdense University Hospital; Aalborg University HospitalRecruitingTranscatheter Aortic Valve ImplantationDenmark
-
French Cardiology SocietyRecruitingTranscatheter Aortic Valve ImplantationFrance
-
Henry Ford Health SystemHenry Ford HospitalCompletedTranscatheter Aortic Valve ImplantationUnited States
-
NVT GmbHCompletedTranscatheter Aortic Valve ImplantationGermany
-
Cardiapex Ltd.TerminatedTransapical Transcatheter Aortic Valve ImplantationGermany
-
University of South FloridaSouthern Bone & Joint Specialists, P.A.CompletedSocket Designs of Transfemoral Amputees.United States
-
ElsanEuropean Clinical Trial Experts Network; Belledonne clinicRecruitingQuality of Life | Aortic Valve Replacement | Transfemoral ApproachFrance
Clinical Trials on different blood pressure intervals
-
Sun Yat-sen UniversityActive, not recruiting
-
Elisabeth-TweeSteden ZiekenhuisBuddhist Tzu Chi General Hospital; European Commission; Eindhoven University... and other collaboratorsCompleted
-
Lokien van NunenCavis Technologies ABCompleted
-
University of CambridgeUniversity of Oxford; National Health Service, Blood and TransplantUnknown
-
University Hospital "Sestre Milosrdnice"CompletedSTEMI - ST Elevation Myocardial Infarction | Myocardial ReperfusionCroatia
-
Meir Medical CenterNovartis PharmaceuticalsTerminatedBlood Pressure, HighIsrael
-
Renaissance University Ugbawka, EnuguEnrolling by invitation
-
Ospedale Regionale di LocarnoCompletedErythropoiesis Stimulating Agent PharmacodynamicsSwitzerland